More on CYAD
Data
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $0.47 |
|
|||
| Open | $84.12 | ||||
| 52 Wk High | $59.50 | ||||
| 52 Wk Low | $16.31 | ||||
| Day High | $0.47 | ||||
| Day Low | $0.47 | ||||
| P/E | N/A | ||||
| EPS | $0.00 | ||||
| Volume | 925,927 | ||||
- Celyad Oncology Reports Full Year 2025 Financial Results and Business Highlights
- Celyad Oncology Announces the Sale of C-CATHez ® Catheter
- Celyad Oncology: Publication of a Transparency Notification Received From Fortress Investment Group LLC (Article 14 §1 of the Law of 2 May 2007)
- Celyad Oncology: Information on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 May 2007)
- Celyad Oncology Announces Research Facility Divestiture
- Celyad Oncology Reports First Half Year 2025 Financial Results
- Celyad Oncology SA: Publication of a Transparency Notification Received From Fortress Investment Group LLC (Article 14 §1 of the Law of 2 May 2007)
- Celyad Oncology SA: Information on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 May 2007)
- Celyad Oncology Announces Discontinuation of R&D Activities
- Celyad Oncology SA: Publication of a Transparency Notification Received from Fortress Investment Group LLC
Entities mentioned with cyad
- Twitter | View Related Stories »
- Earnings | View Related Stories »
- Definitive Agreement | View Related Stories »
- FDA | View Related Stories »
- Wells Fargo | View Related Stories »
- William Blair | View Related Stories »
- Jefferies & Co | View Related Stories »
- IPO | View Related Stories »
- Show More...
